David Tsao Sells 10,000 Shares of Billiontoone (NASDAQ:BLLN) Stock

Billiontoone, Inc. (NASDAQ:BLLN) CTO David Tsao sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $100.00, for a total transaction of $1,000,000.00. Following the completion of the transaction, the chief technology officer directly owned 1,000 shares of the company’s stock, valued at $100,000. This represents a 90.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Tsao also recently made the following trade(s):

• On Monday, August 10th, David Tsao sold 10,000 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total transaction of $928,600.00.
• On Monday, June 15th, David Tsao sold 20,000 shares of Billiontoone stock. The shares were sold at an average price of $102.27, for a total transaction of $2,045,400.00.

Billiontoone Stock Down 1.1%

Shares of BLLN traded down $1.07 during mid-day trading on Thursday, reaching $95.15. The company’s stock had a trading volume of 670,193 shares, compared to its average volume of 841,632. The company has a market cap of $4.49 billion and a price-to-earnings ratio of 137.46. The business has a fifty day moving average of $115.34 and a 200 day moving average of $95.29. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. Billiontoone, Inc. has a 1 year low of $61.96 and a 1 year high of $150.44.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The company had revenue of $109.45 million during the quarter. As a group, analysts forecast that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

BLLN has been the topic of a number of analyst reports. Guggenheim began coverage on shares of Billiontoone in a research report on Monday, June 29th. They issued a “buy” rating and a $125.00 price target on the stock. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. JPMorgan Chase & Co. lowered their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a report on Thursday, August 6th. BTIG Research cut their price target on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, August 6th. Finally, Wall Street Zen cut shares of Billiontoone from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Six analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Billiontoone has a consensus rating of “Moderate Buy” and an average target price of $126.71.

Hedge Funds Weigh In On Billiontoone

Several institutional investors and hedge funds have recently modified their holdings of the business. The Manufacturers Life Insurance Company lifted its position in shares of Billiontoone by 151.8% during the 1st quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock valued at $2,408,000 after acquiring an additional 18,389 shares during the period. Sei Investments Co. bought a new stake in shares of Billiontoone during the 1st quarter worth $1,058,000. Wasatch Advisors LP lifted its position in shares of Billiontoone by 40.2% during the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after buying an additional 148,446 shares during the last quarter. Emerald Mutual Fund Advisers Trust boosted its stake in Billiontoone by 11.9% in the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock valued at $10,436,000 after buying an additional 14,072 shares in the last quarter. Finally, Perceptive Advisors LLC raised its stake in Billiontoone by 26.1% during the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after acquiring an additional 19,000 shares in the last quarter.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.